On January 29, 2009, the FDA granted traditional approval for Isentress (raltegravir) 400 mg tablets in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients.
The details can be read here.
No comments:
Post a Comment